| Food Products Industry | Consumer Staples Sector | Dr. Rajendran Manickavasagar B Ph.(Hons) CEO | CXA Exchange | - ISIN |
| Australia Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Holista CollTech Limited is a biotech company with a strong emphasis on research, having operations in Australia, Malaysia, and the United States. The company spans its operations across multiple segments, including Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate operations. Based in Subiaco, Australia, Holista CollTech is committed to the innovation and production of health-related products that cater to the needs of consumers globally. With a focus on creating products that align with modern health concerns, such as dietary needs and infection prevention, the company has positioned itself as a player in the health and wellness industry, leveraging scientific research to offer solutions that improve quality of life.
Manufactures and wholesales a range of dietary supplements aimed at improving health and wellness through nutrition. These supplements are designed to cater to various health needs, providing essential nutrients and supporting overall health improvement.
Produces cosmetic grade collagen, focusing on the beauty sector. This product aims to meet the demand for high-quality collagen used in skin care and beauty products, promoting skin health and aesthetic improvements.
Offers solutions focused on infection control, vital in the current global health landscape. These products serve as preventative measures against infectious diseases, highlighting the company's commitment to public health and safety.
Develops and supplies food ingredients that contribute to a healthy diet. Among these products are low-Glycemic Index (GI) bread, noodles/pasta, and flatbreads, catering to individuals seeking to manage their blood sugar levels. Additionally, a low-calorie/Low-GI sugar substitute is available, offering a healthier alternative to traditional sugar.